Document is current
Any future updates will be listed below
-
Authors
Bashour, Habib http://orcid.org/0000-0001-6660-1843
Smorodina, Eva http://orcid.org/0000-0002-5457-5163
Pariset, Matteo
Zhong, Jahn http://orcid.org/0000-0002-7247-1392
Akbar, Rahmad http://orcid.org/0000-0002-6692-0876
Chernigovskaya, Maria
Lê Quý, Khang
Snapkow, Igor
Rawat, Puneet
Krawczyk, Konrad http://orcid.org/0000-0003-0697-5522
Sandve, Geir Kjetil http://orcid.org/0000-0002-4959-1409
Gutierrez-Marcos, Jose http://orcid.org/0000-0002-5441-9080
Gutierrez, Daniel Nakhaee-Zadeh
Andersen, Jan Terje http://orcid.org/0000-0003-1710-1628
Greiff, Victor http://orcid.org/0000-0003-2622-5032
- License Information
-
More Information
Article History
Received: 25 January 2024
Accepted: 5 July 2024
First Online: 31 July 2024
Competing interests
: The authors declare the following competing interests: V.G. declares advisory board positions in aiNET GmbH, Enpicom B.V, Absci, Omniscope, and Diagonal Therapeutics. V.G. is a consultant for Adaptyv Biosystems, Specifica Inc, Roche/Genentech, immunai, Proteinea and LabGenius. H.B. declares a scientific writing post in PipeBio ApS. K.K. is the founder of NaturalAntibody. M.P. and D.N-Z.G. are employed by Adaptyv Biosystems.
